Pregled bibliografske jedinice broj: 735181
Donepezil combined with cobalamin substitution in the treatment of patients with mild Alzheimer's disease and subnormal serum cobalamin levels: five case reports
Donepezil combined with cobalamin substitution in the treatment of patients with mild Alzheimer's disease and subnormal serum cobalamin levels: five case reports // Neurologia Croatica 63 (Suppl. 2) - Abstracts of the Croatian Congress on Alzheimer’s Disease (CROCAD-14) with International Participation / Šimić, Goran ; Mimica, Ninoslav (ur.).
Zagreb: Denona, 2014. str. 109-109 (poster, međunarodna recenzija, sažetak, stručni)
CROSBI ID: 735181 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Donepezil combined with cobalamin substitution in the treatment of patients with mild Alzheimer's disease and subnormal serum cobalamin levels: five case reports
Autori
Vilibić, Maja ; Jukić, Vlado ; Mimica, Ninoslav ; Subić, Helena
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Neurologia Croatica 63 (Suppl. 2) - Abstracts of the Croatian Congress on Alzheimer’s Disease (CROCAD-14) with International Participation
/ Šimić, Goran ; Mimica, Ninoslav - Zagreb : Denona, 2014, 109-109
Skup
Hrvatski kongres o Alzheimerovoj bolesti s međunarodnim sudjelovanjem (CROCAD-14)
Mjesto i datum
Brela, Hrvatska, 01.10.2014. - 04.10.2014
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Mild Alzheimer's disease; AD; serum cobalamin levels; donepezil
Sažetak
Aim: To present five case reports of patients with mild Alzheimer's disease (AD) and subnormal serum cobalamin levels, successfully treated with combination of donepezil and cobalamin substitution. Methods: Five patients with mild [baseline Mini-Mental State Examination (MMSE) score 21-26] probable/ possible AD, according to National Institute of Neurological and Communicative Dosorders and Stroke and the Alzhemers Disease and Related Disorders Association (NINCDS/ADRDA) criteria and subnormal serum cobalamin levels were treated with 10 mg donepezil/day orally and received cobalamin substitution parenterally. After one year follow-up period, changes in MMSE and Clinical Global Impression- Improvement (CGI-I) Score were used to objectivize changes in patient psychic status and functioning. Results: Ali five patients completed follow-up. Donepezil was generally well tolerated and only one patient ftported one side-effect: mild nausea of five days duration (first five days after donepezilprescription) that spontaneously recovered. CGI-I suggested „minimal improvements" regarding cognition and patient functioning in four of five treated patients while in one patient there were „no changes" at the end of one year follow-up. Conclusion: Donepezil in combination with parenteral cobalamin substitution therapy may be beneficial for patients with mild AD and subnormal serum cobalamin levels. Structured studies on large sample populations and of various design are needed to clarify clinical significance of our preliminary positive findings.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Napomena
Indexed / Abstracted in: SCOPUS
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče